The investigators will conduct a randomized controlled trial comparing two strategies to promote HCV screening, follow-up testing, and treatment among Parkland patients who are 18 years or older who have elevated liver functioning test (LFT) results: in reach with electronic medical record alerts and provider education vs. combination of in reach and provider education plus mailed outreach and patient navigation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
The investigators will randomize elevated LFT patients (\~12,000 patients) using a centrally maintained computer-generated list. Patients will be randomly assigned to one of two HCV screening strategies including: visit-based screening as part of usual care (Group 1) or mailed screening invitation outreach and centralized patient navigation (Group 2).
Parkland Hospital
Dallas, Texas, United States
Hepatitis C Screening
Proportion with HCV Ab or HCV VL within 6 months of randomization
Time frame: 6 months
Hepatitis C Screening
Proportion with HCV Ab within 12 months of randomization
Time frame: 12 months
Hepatitis C Confirmation
Proportion with HCV Viral Load within 3 months of positive antibody result
Time frame: 3 months
Hepatitis C Linkage to Care
Proportion with clinic visit within 6 months of positive HCV Viral Load
Time frame: 6 months
Cost Per Patient Screened
The primary measure of costs will be the cost per Ab completion.
Time frame: 3 months
Cost Per HCV Diagnosis
The primary measure of costs will be the cost per-patient diagnosed with HCV.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.